Trajectory and risk factors for chemotherapy‐induced nausea and vomiting in Asian patients with head and neck cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|9|1349-1357

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.9, 2015-09, pp. : 1349-1357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Psychosocial Variables on Chemotherapy-Induced Nausea and Vomiting and Health-Related Quality of Life among Cancer Patients: A European Study

By  

Psychotherapy and Psychosomatics, Vol. 84, Iss. 6, 2015-0 ,pp. : 339-347

Karger

Access to resources Recommend Favorite

Does previous chemotherapy‐induced nausea and vomiting predict postoperative nausea and vomiting?

By  

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol. 59, Iss. 9, 2015-10 ,pp. : 1145-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 915-915

John Wiley & Sons Inc

Access to resources Recommend Favorite